Disorders of gut–brain interaction (DGBI) often overlap with non-gastrointestinal conditions such as fibromyalgia, headaches, gynecological and urological disorders, sleep disturbances,…
Browsing: Clinical Updates
In this episode of the UEG Talks conversation between Maria Vehreschild and Pradeep Mundre, we delve into the complexities of…
A new investigational blood test for colorectal cancer (CRC) demonstrated encouraging results in the PREEMPT CRC study, the largest trial…
In this week’s Impact Factor, Dr. F. Perry Wilson delves into the latest study on GLP-1 receptor agonists—drugs like Ozempic…
A new multimodal stool nucleic acid (mm-sNA) test, ColoAlert by Mainz Biomed, has shown remarkable sensitivity and specificity in detecting…
Exact Sciences has released promising results from its trial of the Oncodetect test, designed to identify molecular residual disease (MRD)…
A recent analysis from the University of Pittsburgh Medical Center highlights that nearly half of patients prescribed multitarget stool DNA…
Guardant Health has announced that its Guardant Reveal test, a blood-based assay for minimal residual disease (MRD) detection, is now…
Oshi Health has released its 2024 Impact Report, showcasing the transformative impact of its virtual, multidisciplinary GI care model on…
The rising cost of colonoscopies and restrictive U.S. insurance policies are deterring young adults from timely colorectal cancer (CRC) testing,…